Skip to main content

Table 3 Characteristics associated with epidemiologic links being identified by CLI TB patient interviews (Step 4) versus earlier in CLI (Steps 1–3)

From: Validation of genotype cluster investigations for Mycobacterium tuberculosis: application results for 44 clusters from four heterogeneous United States jurisdictions

 

Epi-linked patient-pairs with concordant PCRTypes

Unadjusted

Adjusteda

Identified without CLI TB patient interviews (n = 158)

Identified by CLI TB patient interviews (n = 30)

OR

p-value

95 % CI

OR

p-value

95 % CI

Study site, n (%)

 Texas (City of Houston)

45 (28.5 %)

15 (50.0 %)

2.51

0.226

0.57, 11.16

0.20

0.191

0.02, 2.25

 Massachusetts

26 (16.5 %)

2 (6.7 %)

0.36

0.218

0.07, 1.82

0.04

0.004

0.00, 0.35

 Maryland

48 (30.4 %)

1 (3.3 %)

0.08

0.050

0.01, 1.00

0.01

0.036

0.00, 0.73

 Georgia

39 (24.7 %)

12 (40.0 %)

2.03

0.357

0.45, 9.22

--

  

Race/ethnicity, n (%)

 Asian

4 (2.5 %)

5 (16.7 %)

7.70

<0.001

3.12, 19.00

0.28

0.349

0.02, 4.07

 Black

93 (58.9 %)

6 (20.0 %)

0.18

0.010

0.05, 0.66

0.21

0.036

0.05, 0.90

 Hispanic

32 (20.1 %)

13 (43.3 %)

3.01

0.211

0.53, 16.97

--

  

 White

24 (10.8 %)

6 (10.0 %)

1.11

0.889

0.25, 4.94

--

  

Transmission setting, n (%)

 Household

29 (18.4 %)

0 (0.0 %)

 

NA

 

--

  

 Close social

27 (17.1 %)

2 (6.7 %)

0.35

0.147

0.08, 1.45

--

  

 Workplace

5 (3.2 %)

4 (13.3 %)

4.71

0.015

1.36, 16.35

7.16

0.032

1.19, 43.08

 Shelter

58 (36.7 %)

4 (13.3 %)

0.27

0.139

0.05, 1.54

--

  

 Church

5 (3.2 %)

8 (26.7 %)

11.13

0.051

0.99, 125.43

10.98

0.046

1.04, 116.08

 Drug house

17 (10.8 %)

2 (6.7 %)

0.59

0.579

0.09, 3.76

--

  

 Other

17 (10.8 %)

10 (33.3 %)

0.24

0.047

0.06, 0.98

0.25

0.024

0.08, 0.83

Relationship between case pairs, n (%)

 Relative

25 (15.8 %)

0 (0.0 %)

 

NA

 

--

  

 Friend

41 (26.0 %)

4 (13.3 %)

0.44

0.204

0.12, 1.56

--

  

 Coworker

4 (2.5 %)

4 (13.3 %)

5.92

0.008

1.58, 22.27

--

  

Genotype lineage, n (%)

 East Asian (L2) lineage

30 (19.0 %)

12 (40.0 %)

2.84

0.118

0.77, 10.54

0.98

0.976

0.19, 5.07

 Euro-American (L4) lineage

122 (77.2 %)

18 (60.0 %)

0.44

0.229

0.12, 1.67

--

  

Common genotype in US†, n (%)

8 (5.1 %)

2 (6.7 %)

1.34

0.709

0.29, 6.21

--

  

Extra-pulmonary only site of TB, n (%)

8 (5.1 %)

6 (20.0 %)

4.69

0.033

1.13, 19.42

9.54

0.105

0.62, 146.32

US-birth, n (%)

132 (83.5 %)

24 (80.0 %)

0.79

0.739

0.19, 3.21

--

  

HIV infection, n (%)

54 (34.2 %)

6 (20.0 %)

0.48

0.301

0.12, 1.92

--

  

Incarcerated at TB diagnosis, n (%)

10 (6.3 %)

1 (3.3 %)

0.51

0.567

0.05, 5.10

--

  

Homeless, n (%)

83 (52.5 %)

8 (26.7 %)

0.33

0.136

0.08, 1.42

--

  

Excess alcohol use, n (%)

112 (70.9 %)

15 (50.0 %)

0.41

0.146

0.12, 1.37

--

  

Non-injection drug use, n (%)

70 (44.3 %)

8 (26.7 %)

0.46

0.058

0.20, 1.03

0.48

0.118

0.19, 1.21

Patient pairs with different zip codes in same jurisdiction, n (%)

99 (66.9 %)

22 (88.0 %)

3.63

0.022

1.21, 10.89

2.84

0.174

0.63, 12.83

Patient pairs from different jurisdictions, n (%)

10 (6.3 %)

5 (16.7 %)

2.96

0.103

0.81, 10.89

4.41

0.070

0.89, 21.95

Epidemiologic link strength = “definite”, n (%)

114 (72.2 %)

10 (33.3 %)

0.19

<0.001

0.08, 0.45

0.22

0.007

0.22, 43.23

  1. OR odds ratio, CI confidence interval, CLI cluster investigation
  2. aAdjusted in the multivariate model. The final model included study site, race/ethnicity, transmission setting, genotype lineage, TB site, non-injection drug use, pairs with different zip codes in same jurisdiction, pairs from different jurisdictions and definite epi-link link strength
  3. †PCRTypes associated with > 400 TB patients in the U.S. 2006-2010 and reported in > 40 states (PCR00002, PCR00015, PCR00022, PCR00041)